Dow Jones

40,003.59

0.34%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

CONX

CONX (CONX)

CONX Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CONX

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
01/05/2024	18:45	PR Newswire (US)	CONX Corp. Announces Closing of Initial Business Combination	NASDAQ:CONX	CONX Corporation
29/04/2024	19:00	PR Newswire (US)	CONX Corp. Announces Final Tender Offer Results	NASDAQ:CONX	CONX Corporation
15/04/2024	17:00	PR Newswire (US)	CONX Corp. Announces Change in Tender Offer Price to Complete Business Combination	NASDAQ:CONX	CONX Corporation
01/04/2024	15:30	PR Newswire (US)	CONX Corp. Announces Tender Offer to Complete Business Combination	NASDAQ:CONX	CONX Corporation
06/06/2023	15:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CONX	CONX Corporation
09/05/2023	15:43	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CONX	CONX Corporation
09/05/2023	15:33	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CONX	CONX Corporation
28/04/2023	15:38	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:CONX	CONX Corporation
10/03/2023	15:31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CONX	CONX Corporation
01/03/2023	16:13	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CONX	CONX Corporation
14/02/2023	10:01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CONX	CONX Corporation
14/02/2023	09:10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CONX	CONX Corporation
01/11/2022	16:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CONX	CONX Corporation
12/10/2022	19:00	PR Newswire (US)	CONX Files Proxy Statement for Stockholders to Vote on Extension of Completion Period; Discloses Preliminary Discussions Regarding Business Combination	NASDAQ:CONX	CONX Corporation
04/02/2022	15:40	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:CONX	CONX Corporation
11/02/2010	08:15	PR Newswire (US)	Corgenix Reports Second Quarter Fiscal 2010 Financial Results	NASDAQ:CONX
08/02/2010	08:15	PR Newswire (US)	Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and	NASDAQ:CONX
02/02/2010	08:15	PR Newswire (US)	Corgenix to Host Conference Call to Discuss Fiscal 2010 Second Quarter Results	NASDAQ:CONX
14/12/2009	08:15	PR Newswire (US)	Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM)	NASDAQ:CONX
12/11/2009	08:15	PR Newswire (US)	Corgenix Reports Financial Results for First Quarter of Fiscal 2010	NASDAQ:CONX
03/11/2009	08:15	PR Newswire (US)	Corgenix to Host Conference Call to Discuss Fiscal 2010 First Quarter Results	NASDAQ:CONX
22/10/2009	08:15	PR Newswire (US)	American Medical Association Establishes New CPT Code for Corgenix AspirinWorks(R) Test Kit	NASDAQ:CONX
06/10/2009	08:15	PR Newswire (US)	Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million	NASDAQ:CONX
25/09/2009	15:06	PR Newswire (US)	/U P D A T E D - Corgenix Medical Corporation/	NASDAQ:CONX
25/09/2009	11:21	PR Newswire (US)	/C O R R E C T I O N -- Corgenix Medical Corporation/	NASDAQ:CONX
25/09/2009	08:15	PR Newswire (US)	Corgenix Reports Fiscal 2009 Financial Results	NASDAQ:CONX
11/09/2009	08:15	PR Newswire (US)	Corgenix to Host Conference Call to Discuss Fiscal 2009 Results	NASDAQ:CONX
09/07/2009	11:15	PR Newswire (US)	Corgenix to Exhibit AspirinWorks(R) Test at 2009 ISTH Meeting	NASDAQ:CONX
14/05/2009	08:15	PR Newswire (US)	Corgenix Reports Third Quarter Fiscal 2009 Financial Results	NASDAQ:CONX
07/05/2009	08:15	PR Newswire (US)	Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program	NASDAQ:CONX